Browse > Article
http://dx.doi.org/10.4062/biomolther.2022.024

p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice  

Lee, Ju-Hyun (Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University)
Son, Seung-Hwan (Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University)
Kim, Nam-Jung (Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University)
Im, Dong-Soon (Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.30, no.6, 2022 , pp. 501-509 More about this Journal
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disorder. Suppression of MAPKs and NF-κB is implicated as a vital mechanism of action of several traditional Chinese medicines for AD therapy. Although overexpression of MAPK mRNA in the skin tissue has been shown in the AD model, the roles of each MAPK in AD pathogenesis have rarely been studied. This study examined the effect of NJK14047, an inhibitor of p38 MAPKs, on AD-like skin lesions induced in BALB/c mice by sensitization and challenges with 1-chloro-2,4-dinitrobenzene (CDNB) on dorsal skin and ears, respectively. After induction of AD, NJK14047 (2.5 mg/kg) or dexamethasone (10 mg/kg) was administrated for 3 weeks via intraperitoneal injection. Following its administration, NJK14047 suppressed CDNB-induced AD-like symptoms such as skin hypertrophy and suppressed mast cell infiltration into the skin lesions. It also reduced CDNB-induced increase in TH2 cytokine (IL-13) and TH1 cytokines (interferon-γ and IL-12A) levels but did not decrease serum IgE level. Furthermore, NJK14047 blocked CDNB-induced lymph node enlargement. These results suggest that NJK14047, a p38 MAPK inhibitor, might be an optimal therapeutic option with unique modes of action for AD treatment.
Keywords
Atopy; Dermatitis; NJK14047; Immunopharmacology; p38 MAPK;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Muraro, A., Lemanske, R. F., Jr., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., Simon, H. U., Seys, S. F. and Agache, I. (2016) Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 137, 1347-1358.   DOI
2 Liu, F.-T., Goodarzi, H. and Chen, H.-Y. (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41, 298-310.   DOI
3 Min, G.-Y., Kim, J.-H., Kim, T.-I., Cho, W.-K., Yang, J.-H. and Ma, J.-Y. (2022) Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro. Int. J. Mol. Sci. 23, 553.   DOI
4 Nath, P., Leung, S.-Y., Williams, A., Noble, A., Chakravarty, S. D. S., Luedtke, G. R., Medicherla, S., Higgins, L. S., Protter, A. and Chung, K. F. (2006) Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur. J. Pharmacol. 544, 160-167.   DOI
5 Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suarez-Farinas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., Pensabene, C., Coats, I., Novitskaya, I., Lowes, M. A. and Krueger, J. G. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102.
6 Ono, K. and Han, J. (2000) The p38 signal transduction pathway activation and function. Cell. Signal. 12, 1-13.   DOI
7 Schafer, P. H., Wadsworth, S. A., Wang, L. and Siekierka, J. J. (1999) p38α mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+ CD45RO+ T cells and Th2 effector cells. J. Immunol. 162, 7110-7119.   DOI
8 Souwer, Y., Szegedi, K., Kapsenberg, M. L. and de Jong, E. C. (2010) IL-17 and IL-22 in atopic allergic disease. Curr. Opin. Immunol. 22, 821-826   DOI
9 Niiro, H. and Clark, E. A. (2002) Regulation of B-cell fate by antigenreceptor signals. Nat. Rev. Immunol. 2, 945-956.   DOI
10 Nel, A. E. (2002) T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 109, 758-770.   DOI
11 Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G. and Guttman-Yassky, E. (2009) IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123, 1244-1252. e2.   DOI
12 Oh, M.-H., Oh, S. Y., Yu, J., Myers, A. C., Leonard, W. J., Liu, Y. J., Zhu, Z. and Zheng, T. (2011) IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J. Immunol. 186, 7232-7242.   DOI
13 Park, S. J. and Im, D. S. (2019) Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice. Br. J. Pharmacol. 176, 938-949.   DOI
14 Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J. S., Lee, M. S. and Yang, Y. (2018) Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells. Mol. Med. Rep. 18, 1095-1103.
15 Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H. and Matsushima, K. (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104, 1097-1105.   DOI
16 Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y., Lipozencic, J., Luger, T. A., Muraro, A., Novak, N., Platts-Mills, T. A., Rosenwasser, L., Scheynius, A., Simons, F. E., Spergel, J., Turjanmaa, K., Wahn, U., Weidinger, S., Werfel, T. and Zuberbier, T.; European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. J. Allergy Clin. Immunol. 118, 152-169.
17 Bai, X.-Y., Liu, P., Chai, Y.-W., Wang, Y., Ren, S.-H., Li, Y.-Y. and Zhou, H. (2020) Artesunate attenuates 2, 4-dinitrochlorobenzeneinduced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice. Eur. J.Pharmacol. 874, 173020.   DOI
18 Bantz, S. K., Zhu, Z. and Zheng, T. (2014) The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell. Immunol. 5, 202.
19 Blume-Peytavi, U. and Wahn, U. (2011) Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J. Eur. Acad. Dermatol. Venereol. 25, 508-515.   DOI
20 Chen, C.-H., Zhang, D.-H., LaPorte, J. M. and Ray, A. (2000) Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165, 5597-5605.   DOI
21 Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B. and Chan, L. (2004) Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin. Exp. Immunol. 138, 375-387.   DOI
22 Duan, W., Chan, J. H., McKay, K., Crosby, J. R., Choo, H. H., Leung, B. P., Karras, J. G. and Wong, W. F. (2005) Inhaled p38α mitogenactivated protein kinase antisense oligonucleotide attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 171, 571-578.   DOI
23 Chen, Y., Xian, Y. F., Loo, S., Lai, Z., Chan, W. Y., Liu, L. and Lin, Z. X. (2020) Huang-Lian-Jie-Du extract ameliorates atopic dermatitislike skin lesions induced by 2,4-dinitrobenzene in mice via suppression of MAPKs and NF-κB pathways. J. Ethnopharmacol. 249, 112367.   DOI
24 Choi, M.-S., Heo, J., Yi, C.-M., Ban, J., Lee, N.-J., Lee, N.-R., Kim, S. W., Kim, N.-J. and Inn, K.-S. (2016) A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virusinduced p38 MAPK activation. Biochem. Biophys. Res. Commun. 477, 311-316.   DOI
25 Davidson, W. F., Leung, D. Y. M., Beck, L. A., Berin, C. M., Boguniewicz, M., Busse, W. W., Chatila, T. A., Geha, R. S., Gern, J. E., Guttman-Yassky, E., Irvine, A. D., Kim, B. S., Kong, H. H., Lack, G., Nadeau, K. C., Schwaninger, J., Simpson, A., Simpson, E. L., Spergel, J. M., Togias, A., Wahn, U., Wood, R. A., Woodfolk, J. A., Ziegler, S. F. and Plaut, M. (2019) Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: mechanisms and interventions". J. Allergy Clin. Immunol. 143, 894-913.
26 Hengge, U. R., Ruzicka, T., Schwartz, R. A. and Cork, M. J. (2006) Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54, 1-15.   DOI
27 Koprak, S., Staruch, M. J. and Dumont, F. J. (1999) A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192, 87-95.   DOI
28 Kumar, S., Boehm, J. and Lee, J. C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726.   DOI
29 Gee, M. S., Kim, S.-W., Kim, N., Lee, S. J., Oh, M. S., Jin, H. K., Bae, J.-S., Inn, K.-S., Kim, N.-J. and Lee, J. K. (2018) A novel and selective p38 mitogen-activated protein kinase inhibitor attenuates LPS-induced neuroinflammation in BV2 microglia and a mouse model. Neurochem. Res. 43, 2362-2371.   DOI
30 Hale, K. K., Trollinger, D., Rihanek, M. and Manthey, C. L. (1999) Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J. Immunol. 162, 4246-4252.   DOI
31 Huang, J., Su, M., Lee, B. K., Kim, M. J., Jung, J. H. and Im, D. S. (2018) Suppressive effect of 4-hydroxy-2-(4-hydroxyphenethyl) isoindoline-1,3-dione on ovalbumin-induced allergic asthma. Biomol. Ther. (Seoul) 26, 539-545.   DOI
32 Imai, Y. (2019) Interleukin-33 in atopic dermatitis. J. Dermatol. Sci. 96, 2-7.   DOI
33 Kang, J. and Im, D. S. (2020) FFA2 activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. Biomol. Ther. (Seoul) 28, 267-271.   DOI
34 Kawakami, T. and Galli, S. J. (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2, 773-786. Kim, J. Y., Jeong, M. S., Park, M. K., Lee, M. K. and Seo, S. J. (2014) Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice. Exp. Dermatol. 23, 53-57.
35 Maneechotesuwan, K., Xin, Y., Ito, K., Jazrawi, E., Lee, K.-Y., Usmani, O. S., Barnes, P. J. and Adcock, I. M. (2007) Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA3. J. Immunol. 178, 2491-2498.   DOI
36 Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W., Strickler, J. E., McLaughlin, M. M., Siemens, I. R., Fisher, S. M., Livi, G. P., White, J. R., Adams, J. L. and Young, P. R. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.   DOI
37 Leung, D. Y. and Guttman-Yassky, E. (2017) Assessing the current treatment of atopic dermatitis: unmet needs. J. Allergy Clin. Immunol. 139, S47-S48.   DOI
38 Leung, D. Y. and Soter, N. A. (2001) Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 44, S1-S12.   DOI
39 Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M. and Tokura, Y. (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128, 2625-2630.   DOI
40 Lu, B., Ferrandino, A. F. and Flavell, R. A. (2004) Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat. Immunol. 5, 38-44.   DOI
41 Mori, A., Kaminuma, O., Miyazawa, K., Ogawa, K., Okudaira, H. and Akiyama, K. (1999) p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis. J. Immunol. 163, 4763-4771.   DOI
42 Underwood, D. C., Osborn, R. R., Kotzer, C. J., Adams, J. L., Lee, J. C., Webb, E. F., Carpenter, D. C., Bochnowicz, S., Thomas, H. C., Hay, D. W. and Griswold, D. E. (2000) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293, 281-288.
43 Escott, K., Belvisi, M., Birrell, M., Webber, S., Foster, M. and Sargent, C. (2000) Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat. Br. J. Pharmacol. 131, 173-176.   DOI
44 Saklatvala, J. (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Cur. Opin. Pharmacol. 4, 372-377.   DOI
45 Skapenko, A., Lipsky, P. E., Kraetsch, H.-G., Kalden, J. R. and Schulze-Koops, H. (2001) Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J. Immunol. 166, 4283-4292.   DOI
46 Song, H.-Y., Kim, W. S., Mushtaq, S., Park, J. M., Choi, S.-H., Cho, J.-W., Lim, S.-T. and Byun, E.-B. (2019) A novel chrysin derivative produced by gamma irradiation attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in Balb/cmice. Food Chem. Toxicol. 128, 223-232.   DOI
47 Spergel, J. M., Mizoguchi, E., Oettgen, H., Bhan, A. K. and Geha, R. S. (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103, 1103-1111.   DOI
48 Kalesnikoff, J., Huber, M., Lam, V., Damen, J. E., Zhang, J., Siraganian, R. P. and Krystal, G. (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801-811.   DOI
49 Gee, M. S., Son, S. H., Jeon, S. H., Do, J., Kim, N., Ju, Y.-J., Lee, S. J., Chung, E. K., Inn, K.-S., Kim, N.-J. and Lee, J. K. (2020) A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimer's Res. Ther. 12, 45.   DOI
50 Heo, J., Shin, H., Lee, J., Kim, T., Inn, K.-S. and Kim, N.-J. (2015) Synthesis and biological evaluation of N-cyclopropylbenzamidebenzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors. Bioorg. Med. Chem. Lett. 25, 3694-3698.   DOI
51 Kim, S.-Y., Kim, H., Kim, S.-W., Lee, N.-R., Yi, C.-M., Heo, J., Kim, B.- J., Kim, N.-J. and Inn, K.-S. (2017) An effective antiviral approach targeting hepatitis B virus with NJK14047, a novel and selective biphenyl amide p38 mitogen-activated protein kinase inhibitor. Antimicrob. Agents Chemother. 61, e00214-17.
52 Ku, J. M., Hong, S. H., Kim, S. R., Choi, H.-S., Kim, H. I., Kim, D. U., Oh, S. M., Seo, H. S., Kim, T. Y., Shin, Y. C., Cheon, C. and Ko, S. G. (2018) The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo. BMC Complement. Altern. Med. 18, 215.   DOI
53 Lee, J. M., Park, S. J. and Im, D. S. (2017) Calcium signaling of lysophosphatidylethanolamine through LPA1 in human SH-SY5Y neuroblastoma cells. Biomol. Ther. (Seoul) 25, 194-201.   DOI
54 Zhang, R., Zhang, H., Shao, S., Shen, Y., Xiao, F., Sun, J., Piao, S., Zhao, D., Li, G. and Yan, M. (2022) Compound traditional Chinese medicine dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in atopic dermatitis. Chin. Med. 17, 3.   DOI